Proteomic profile of carbonylated proteins in rat liver: Discovering possible mechanisms for tetracycline-induced steatosis

Proteomics

Volumn 15, Issue 1, 2015, Pages 148-159

  Deng, Zhenglu ^a   Yan, Siyu ^a   Hu, Hui ^a   Duan, Zhigui ^a   Yin, Lanxuan ^a   Liao, Shenke ^a   Sun, Yubai ^a   Yin, Dazhong ^a,b   Li, Guolin ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b The Fifth Affiliated Hospital of Jinan University   (China)

Author keywords

Animal proteomics; Carbonylation; Nonalcoholic fatty liver disease (NAFLD); Oxidative stress; Rat; Tetracycline

Indexed keywords

ACTIN; ACYL COENZYME A DEHYDROGENASE; ALANINE AMINOTRANSFERASE; ALDEHYDE DEHYDROGENASE; ASPARTATE AMINOTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CALRETICULIN; CARBAMOYL PHOSPHATE SYNTHASE; CATALASE; CHOLESTEROL; CYTOCHROME B5; CYTOCHROME P450 2C11; ELECTRON TRANSFERRING FLAVOPROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTAMATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MALATE DEHYDROGENASE; MALONALDEHYDE; METHYLCROTONOYL COENZYME A CARBOXYLASE; ORNITHINE CARBAMOYLTRANSFERASE; PALMITIC ACID; PROTEIN DISULFIDE ISOMERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SUPEROXIDE DISMUTASE; TETRACYCLINE; THIOSULFATE SULFURTRANSFERASE; TRIACYLGLYCEROL; UBIQUINOL CYTOCHROME C REDUCTASE; ANTIINFECTIVE AGENT; FATTY ACID; PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOTINYLATION; CARBONYLATION; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME MODIFICATION; FATTY ACID OXIDATION; FATTY LIVER; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPID STORAGE; LIPOTOXICITY; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEOMICS; RAT; ANIMAL; CHEMICALLY INDUCED; LIVER; METABOLISM; PATHOLOGY; PROTEIN CARBONYLATION; PROTEIN PROTEIN INTERACTION; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTI-BACTERIAL AGENTS; FATTY ACIDS; FATTY LIVER; HEP G2 CELLS; HUMANS; LIVER; MALE; PROTEIN CARBONYLATION; PROTEIN INTERACTION MAPS; PROTEINS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; TETRACYCLINE;

EID: 84920487911     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400115     Document Type: Article

References (48)

1. Chopra, I., Roberts, M., Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 2001, 65, 232-260.
2. Korting, H. C., Schollmann, C., Tetracycline actions relevant to rosacea treatment. Skin Pharmacol. Physiol. 2009, 22, 287-294.
3. Lehner, G. M., Linek, M., A case of vesicular cutaneous lupus erythematosus in a Border collie successfully treated with topical tacrolimus and nicotinamide-tetracycline. Vet. Dermatol. 2013, 24, 639-641.
4. Westphal, J. F., Vetter, D., Brogard, J. M., Hepatic side-effects of antibiotics. J. Antimicrob. Chemother. 1994, 33, 387-401.
5. Bhagavan, B. S., Wenk, R. E., McCarthy, E. F., Gebhardt, F. C., Lustgarten, J. A., Long-term use of tetracycline. JAMA 1982, 247, 2780.
6. Freneaux, E., Labbe, G., Letteron, P., The Le, D. et al., Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 1988, 8, 1056-1062.
7. Yin, H. Q., Kim, M., Kim, J. H., Kong, G. et al., Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline. Toxicol. Sci. 2006, 94, 206-216.
8. Antherieu, S., Rogue, A., Fromenty, B., Guillouzo, A., Robin, M. A., Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells. Hepatology 2011, 53, 1895-1905.
9. Yu, H. Y., Wang, B. L., Zhao, J., Yao, X. M. et al., Protective effect of bicyclol on tetracycline-induced fatty liver in mice. Toxicology 2009, 261, 112-118.
10. Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W. B. et al., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120, 1183-1192.
11. Patrick, L., Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern. Med. Rev. 2002, 7, 276-291.
12. Dowman, J. K., Tomlinson, J. W., Newsome, P. N., Pathogenesis of non-alcoholic fatty liver disease. QJM 2010, 103, 71-83.
13. Day, C. P., James, O. F., Steatohepatitis: a tale of two "hits"? Gastroenterology 1998, 114, 842-845.
14. Day, C. P., Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16, 663-678.
15. Shen, C., Meng, Q., Schmelzer, E., Bader, A., Gel entrapment culture of rat hepatocytes for investigation of tetracycline-induced toxicity. Toxicol. Appl. Pharmacol. 2009, 238, 178-187.
16. Asha, K. K., Sankar, T. V., Viswanathan Nair, P. G., Effect of tetracycline on pancreas and liver function of adult male albino rats. J. Pharm. Pharmacol. 2007, 59, 1241-1248.
17. Letteron, P., Fromenty, B., Terris, B., Degott, C., Pessayre, D., Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol. 1996, 24, 200-208.
18. Stravitz, R. T., Sanyal, A. J., Drug-induced steatohepatitis. Clin. Liver Dis. 2003, 7, 435-451.
19. Madian, A. G., Regnier, F. E., Proteomic identification of carbonylated proteins and their oxidation sites. J. Proteome Res. 2010, 9, 3766-3780.
20. Irazusta, V., Moreno-Cermeno, A., Cabiscol, E., Tamarit, J., Ros, J., Proteomic strategies for the analysis of carbonyl groups on proteins. Curr Protein Pept Sci 2010, 11, 652-658.
21. Hu, X., Duan, Z., Hu, H., Li, G. et al., Proteomic profile of carbonylated proteins in rat liver: exercise attenuated oxidative stress may be involved in fatty liver improvement. Proteomics 2013, 13, 1755-1764.
22. Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A., Colombo, R., Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329, 23-38.
23. Schwartz, D. M., Wolins, N. E., A simple and rapid method to assay triacylglycerol in cells and tissues. J. Lipid Res. 2007, 48, 2514-2520.
24. Wang, H., Joseph, J. A., Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27, 612-616.
25. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
26. Liu, S., Shi, W., Li, G., Jin, B. et al., Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2011, 26, 1010-1015.
27. Li, G., He, H., Yan, H., Zhao, Q., Yin, D., Does carbonyl stress cause increased blood viscosity during storage? Clin. Hemorheol. Microcirc. 2010, 44, 145-154.
28. Riddles, P. W., Blakeley, R. L., Zerner, B., Hirs, C. H. W., Serge, N. T., Methods in Enzymology, Academic Press, Harcourt 1983, pp. 49-60.
29. Benzie, I. F., Strain, J. J., Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999, 299, 15-27.
30. Fossati, P., Prencipe, L., Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 1982, 28, 2077-2080.
31. Marklund, S., Marklund, G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47, 469-474.
32. Habig, W. H., Pabst, M. J., Jakoby, W. B., Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130-7139.
33. Mirzaei, H., Regnier, F., Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal. Chem. 2005, 77, 2386-2392.
34. Madian, A. G., Regnier, F. E., Profiling carbonylated proteins in human plasma. J. Proteome Res. 2010, 9, 1330-1343.
35. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
36. Huang da, W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
37. Lowenthal, D., Conversation with... David Lowenthal, MD, PhD: practical approaches to geriatric exercise. Interview by Richard L. Peck. Geriatrics 1990, 45, 76, 81-72.
38. Warde-Farley, D., Donaldson, S. L., Comes, O., Zuberi, K. et al., The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010, 38, W214-220.
39. Montojo, J., Zuberi, K., Rodriguez, H., Kazi, F. et al., GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 2010, 26, 2927-2928.
40. Listenberger, L. L., Han, X., Lewis, S. E., Cases, S. et al., Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 2003, 100, 3077-3082.
41. Zhang, D., Liu, Z. X., Choi, C. S., Tian, L. et al., Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc. Natl. Acad. Sci. U S A 2007, 104, 17075-17080.
42. Kurtz, D. M., Rinaldo, P., Rhead, W. J., Tian, L. et al., Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc. Natl. Acad. Sci. U S A. 1998, 95, 15592-15597.
43. Stadtman, E. R., Protein oxidation and aging. Free Radic. Res. 2006, 40, 1250-1258.
44. Postic, C., Girard, J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 2008, 118, 829-838.
45. Letteron, P., Sutton, A., Mansouri, A., Fromenty, B., Pessayre, D., Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 2003, 38, 133-140.
46. Soupene, E., Kuypers, F. A., Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 2008, 233, 507-521.
47. Li, L. O., Ellis, J. M., Paich, H. A., Wang, S. et al., Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J. Biol. Chem. 2009, 284, 27816-27826.
48. Begriche, K., Massart, J., Robin, M. A., Bonnet, F., Fromenty, B., Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013, 58, 1497-1507.